Effect of covalent dimer conjugates of angiotensin II on receptor affinity and activity in vitro.

Angiotensin II [1-8 or 2-8] analogues and [4-8] fragments were dimerized through the amino- or carboxy-terminal groups in order to try to increase their potency as reported for other hormones. The binding affinity to the angiotensin II receptor subtypes A (A IIA) and B (A IIB) was tested and compared to the potency in rabbit aortic ring. The [2-8] dimers coupled through the N-terminus show no significant change in potency in aortic ring. The [4-8] fragments coupled through the N-terminus are inactive in the ring. They have however a significantly increased affinity for the A IIA receptor, the specific function of which has not yet been reported. When angiotensin II analogues or fragments are coupled through the C-terminus, there was a significant drop in affinity and potency, confirming the importance of the free carboxyl group in position 8 for binding and activity. It is concluded that binding to the A IIB receptor correlates well with the effectiveness in aortic ring. However, in contrast to the beneficial effect reported for a large number of other hormones, dimerization of angiotensin II or its fragments is not accompanied by an increased biological activity in aortic ring.

[1]  P. Timmermans,et al.  Identification of angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[2]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[3]  P. Portoghese Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. , 1989, Trends in pharmacological sciences.

[4]  J. Fauchère,et al.  Synthesis and steroidogenic activity of covalently dimerized corticotropin (ACTH) fragments , 1988 .

[5]  J. Fauchère,et al.  Potentiation of the antagonistic effect of ACTH11–24 on steroidogenesis by synthesis of covalent dimeric conjugates , 1985, FEBS letters.

[6]  D. L. Larson,et al.  Opioid agonist and antagonist bivalent ligands as receptor probes. , 1982, Life sciences.

[7]  J. Russell,et al.  Preparation of a disulfide-linked dimer of human placental lactogen fragment 1--134 with immunologic and biologic activity. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Sandman,et al.  Increased analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine enkephalinamide. , 1978, Biochemical and biophysical research communications.

[9]  S. Whitebread,et al.  Binding characteristics and vascular effects of various angiotensin II antagonists. , 1990, Journal of cardiovascular pharmacology.

[10]  M. Stolz Kovalente Dimerisierung von Neuropeptid-Agonisten und Antagonisten , 1988 .